Switch theme
Sign up to access all valuation multiples
Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company’s reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.
1867
633
LTM Revenue $198M
LTM EBITDA $18.8M
$183M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Acme United has a last 12-month revenue (LTM) of $198M and a last 12-month EBITDA of $18.8M.
In the most recent fiscal year, Acme United achieved revenue of $194M and an EBITDA of $20.4M.
Acme United expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Acme United valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $198M | XXX | $194M | XXX | XXX | XXX |
| Gross Profit | $77.8M | XXX | $76.4M | XXX | XXX | XXX |
| Gross Margin | 39% | XXX | 39% | XXX | XXX | XXX |
| EBITDA | $18.8M | XXX | $20.4M | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | 11% | XXX | XXX | XXX |
| EBIT | $14.0M | XXX | $14.1M | XXX | XXX | XXX |
| EBIT Margin | 7% | XXX | 7% | XXX | XXX | XXX |
| Net Profit | $9.7M | XXX | $10.0M | XXX | XXX | XXX |
| Net Margin | 5% | XXX | 5% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $21.1M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Acme United's stock price is $40.
Acme United has current market cap of $151M, and EV of $183M.
See Acme United trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $183M | $151M | XXX | XXX | XXX | XXX | $2.37 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Acme United has market cap of $151M and EV of $183M.
Acme United's trades at 0.9x EV/Revenue multiple, and 8.9x EV/EBITDA.
Equity research analysts estimate Acme United's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Acme United has a P/E ratio of 15.5x.
See valuation multiples for Acme United and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $151M | XXX | $151M | XXX | XXX | XXX |
| EV (current) | $183M | XXX | $183M | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | 9.7x | XXX | 8.9x | XXX | XXX | XXX |
| EV/EBIT | 13.0x | XXX | 12.9x | XXX | XXX | XXX |
| EV/Gross Profit | 2.3x | XXX | n/a | XXX | XXX | XXX |
| P/E | 15.5x | XXX | 15.1x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 37.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAcme United's last 12 month revenue growth is 5%
Acme United's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Acme United's rule of 40 is 21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Acme United's rule of X is 21% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Acme United and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Growth | -11% | XXX | -27% | XXX | XXX | XXX |
| Rule of 40 | 21% | XXX | 15% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 21% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 32% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| PharmaSGP | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Acme United acquired XXX companies to date.
Last acquisition by Acme United was XXXXXXXX, XXXXX XXXXX XXXXXX . Acme United acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Acme United founded? | Acme United was founded in 1867. |
| Where is Acme United headquartered? | Acme United is headquartered in United States of America. |
| How many employees does Acme United have? | As of today, Acme United has 633 employees. |
| Who is the CEO of Acme United? | Acme United's CEO is Mr. Walter C. Johnsen. |
| Is Acme United publicy listed? | Yes, Acme United is a public company listed on ASE. |
| What is the stock symbol of Acme United? | Acme United trades under ACU ticker. |
| When did Acme United go public? | Acme United went public in 1984. |
| Who are competitors of Acme United? | Similar companies to Acme United include e.g. EZZ Life Science, Live Verdure, Lavipharm, Sarantis Group. |
| What is the current market cap of Acme United? | Acme United's current market cap is $151M |
| What is the current revenue of Acme United? | Acme United's last 12 months revenue is $198M. |
| What is the current revenue growth of Acme United? | Acme United revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Acme United? | Current revenue multiple of Acme United is 0.9x. |
| Is Acme United profitable? | Yes, Acme United is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Acme United? | Acme United's last 12 months EBITDA is $18.8M. |
| What is Acme United's EBITDA margin? | Acme United's last 12 months EBITDA margin is 9%. |
| What is the current EV/EBITDA multiple of Acme United? | Current EBITDA multiple of Acme United is 9.7x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
